Abstract
Converting cardiac fibroblasts to cardiomyocytes has been considered as a regenerative strategy for myocardial infarction and other disorders. Recently, Cao et al. 2016 defined a cocktail of 9 chemical compounds with this capability, increasing the likelihood of clinical success.